Top Abstract Purchase Preview Related
Home
>
Node
>
Subnode

Experimental and clinical study on the antiviral activity of jinyebaidu granule against human cytomegalovirus

Wen, L.Z.; Xing, W.

International Journal of Gynaecology and Obstetrics the Official Organ of the International Federation of Gynaecology and Obstetrics 77(2): 149-150

2002

ISSN/ISBN: 0020-7292
PMID: 12031566
DOI: 10.1016/s0020-7292(02)00003-6
Document Number: 242289
A study was conducted to investigate the anti-human cytomegalovirus (HCMV) activity of Jinyebaidu granule (JYBDG), a preparation used in traditional Chinese medicine containing 4 herbs (Jinyinhua, Yuxingcao, Daqingye and Pugongying). 152 non-pregnant women of childbearing age and 218 women who were infected with HCMV were recruited [China; date not given]. Each group was subdivided into a therapeutic group and a control group. The HCMV inhibiting rate in the therapeutic group were 79.49% in non-pregnant women and 80.91% in pregnant women. The fetuses' intrauterine infection rate was 19.12% (13/68) in the therapeutic group, which was apparently lower tan in the control group. ( chi 2=9.625, P=0.002). Results suggest that JYBDG is a safe inhibitory drug that can be used for the treatment of HCMV infection and may prove especially valuable during pregnancy.

Document emailed within 0-6 h
Secure & encrypted payments

Experimental and clinical study on the antiviral activity of jinyebaidu granule against human cytomegalovirus

Taguchi, T. 1990: Clinical results of UFT granule of enteric coating (UFT e granule). Osaka UFT e Granule Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(7): 1295-1301
Jiang, H.; Wen, L.; Ling, X. 1999: The experimental and clinical study of inhibitory effects of Re-Du-Qing on human cytomegalovirus (HCMV) Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 13(2): 175-179
Terlizzi, M.E.; Costa, C.; Astegiano, S.; Sidoti, F.; Vendrame, R.; Segoloni, G.P.; Bergallo, M.; Cavallo, R. 2008: Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies Minerva Medica 99(3): 231-239
Terlizzi, M.E.; Costa, C.; Astegiano, S.; Sidoti, F.; Vendrame, R.; Segoloni, G.P.; Bergallo, M.; Cavallo, R. 2008: Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies Minerva Medica 99(3): 231-239
Gordon, M.; Deeks, S.; De Marzo, C.; Goodgame, J.; Guralnik, M.; Lang, W.; Mimura, T.; Pearce, D.; Kaneko, Y. 1997: Curdlan sulfate (CRDS) in a 21-day intravenous tolerance study in human immunodeficiency virus (HIV) and cytomegalovirus (CMV) infected patients: indication of anti-CMV activity with low toxicity Journal of Medicine 28(1-2): 108-128
Zmushko, E.I.; Mitin, I.A.; Katsalukha, V.V.; Sviridov, L.P.; Nikolaev, V.P.; Starenchenko, V.V. 2003: Cytokinin inducing and antiviral activity of cycloferon on experimental herpetic infection Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 4: 105-107
Novokhatskiĭ, A.S.; Cherkashina, N.P.; Ershov, F.I. 1979: Accelerated method of determining the antiviral activity of interferon inducers in experimental infection Voprosy Virusologii 3: 303-306
Emami-Nouri, M. 1975: A electromyographic study of the vestibular reflexes. a clinical experimental study on human beings Laryngologie Rhinologie Otologie 54(6): 512-530
Christofinis, G.J. 1980: Heterospecific antiviral activity of human interferon on guinea pig endothelial cells Developments in Biological Standardization 46: 193-196
Meshkova, E.N.; Mentkevich, L.M. 1987: Potentiation of the antiviral activity of human interferons by virazole in in vitro experiments Voprosy Virusologii 32(5): 570-573
Krasil'nikov, I.I.; Kalnina, L.B.; Korneeva, M.N.; Nosik, D.N.; Zlobin, A.I.; Vladimirov, V.G.; L'vov, D.K. 1991: Inhibitors of ADP ribosylation as antiviral agents: an experimental study in a model of HIV infection Voprosy Virusologii 36(3): 216-218
Vanden Broecke, C.; Plasman, P.O.; Pirak, M.; Thiry, E.; Schwers, A.; Piscitelli, S.; Ligongo, G.; Pastoret, P.P.; Werenne, J. 1985: Human recombinant interferon in the bovine species: induction of 2'5'A synthetase and antiviral activity Progress in Clinical and Biological Research 202: 333-338
Doenicke, A.; Dittmann-Kessler, I.; Sramoto, A.; Beyer, E. 1980: Etomidate and suxamethonium. the duration of relaxation and pseudocholinesterase activity. a clinical experimental study Der Anaesthesist 29(3): 120-124
Broniarek, E. 1994: Immunologic processes in human placenta and their role in antiviral resistance. I. Virus infections of the uterus. Nonspecific antiviral immunity Postepy Higieny i Medycyny Doswiadczalnej 48(3): 227-241
Shibnev, V.A.; Garaev, T.M.; Finogenova, M.P.; Kalnina, L.B.; Nosik, D.N. 2015: Antiviral activity of aqueous extracts of the birch fungus Inonotus obliquus on the human immunodeficiency virus Voprosy Virusologii 60(2): 35-38
Kontarov, N.A.; Ermakova, A.A.; Grebionkina, N.S.; Yuminova, N.V.; Zverev, V.V. 2015: The study of the antiviral activity of polyelectrolytes with respect to the influenza virus Voprosy Virusologii 60(4): 5-9
Alekseeva, I.I.; Kurinenko, B.M.; Kleiner, G.I.; Skuia, A.Z.; Penzikova, G.A. 1981: Comparative study of the antiviral activity of pancreatic and microbial RNAse Antibiotiki 26(7): 527-532
Qian, Y.-s.; Lv, W.; Sui, L.-h.; Wang, J. 2005: Study on the relationship between genesis and development of cervical cancer and the infection of human papillomavirus type 16/18, human herpesvirus Ii and cytomegalovirus Zhonghua Liu Xing Bing Xue Za Zhi 26(8): 622-625
Stolfi, P.; Merolla, R. 1971: Enzyme activity in the synovial fluid. Changes of acid and alkaline phosphatases. Experimental and clinical study Minerva Medica 62(13): 611-613
Glotov, A.G.; Glotova, T.I.; Sergeev, A.A.; Sergeev, A.N. 2004: Study of antiviral activity of different drugs against bovine herpes virus and pestivirus Antibiotiki i Khimioterapiia 49(6): 6-9